Search results
Pain to purpose: The story of a Stage 4 triple-negative breast cancer survivor
Scripps News via AOL· 6 days agoNow more than seven years cancer-free, Jennifer Greenhut shares her story about the ups and downs of...
Vaccine aims to cure breast cancer before it starts
WKOW 27 Madison· 2 days agoThere is a vaccine in the works to cure breast cancer before it even starts. Anixa Biosciences is the company that is developing it. The Phase ...
Kim D. Blickenstaff Acquires 172,189 Shares of Nuvation Bio Inc. (NYSE:NUVB) Stock
ETF DAILY NEWS· 10 hours agoNuvation Bio Inc. (NYSE:NUVB – Get Free Report) Director Kim D. Blickenstaff purchased 172,189 shares of Nuvation Bio stock in a transaction dated Tuesday, June 11th. The shares were acquired ...
White Sox Select Chad Kuhl
MLB Trade Rumors· 19 hours agoThe White Sox announced Friday that they’ve selected the contract of right-hander Chad Kuhl from Triple-A Charlotte. Kuhl, 31, is a veteran of seven big...
27-year-old battling rare cancer uses social media to help break stigmas
WTVD-TV 11 Raleigh-Durham· 3 days agoAllen looks at the world through heart shaped lenses -- quite literally. Complementing the 27 year...
ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Significant Decrease in Short Interest
ETF DAILY NEWS· 2 days agoABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the recipient of a significant decrease in short interest in May. As of May 31st, there was short interest totalling 435,100 shares, ...
'We've got to fight for the future': Thousands gather for 32nd Alaska Run for Women
Anchorage Daily News· 6 days agoThis year, she found out firsthand the power of the support and enthusiasm the team comprised of...
Pivotal advancement in the treatment of small cell lung cancer
KHGI Nebraska TV· 2 days ago1 in 16 Americans will face a lung cancer diagnosis in their lifetime.Lung cancer is a complex and...
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains | Investing.com Canada
Investing.com· 20 hours agoShares Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket...
Harry Shuman Sells 7,300 Shares of Merus (NASDAQ:MRUS) Stock
ETF DAILY NEWS· 1 day agoFollowing the completion of the sale, the vice president now owns 7,002 shares in the company, valued at $404,995.68. On Monday, June 10th, Harry Shuman sold 1,000 shares ...